Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("TMC278")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 9 of 9

  • Page / 1
Export

Selection :

  • and

Prevalence of TMC278 (rilpivirine) associated mutations in the Frankfurt Resistance DatabaseREINHEIMER, Claudia; DOERR, Hans W; STURMER, Martin et al.Journal of clinical virology. 2012, Vol 53, Num 3, pp 248-250, issn 1386-6532, 3 p.Article

Etravirine and Rilpivirine : Nonnucleoside Reverse Transcriptase Inhibitors with Activity Against Human Immunodeficiency Virus Type 1 Strains Resistant to Previous Nonnucleoside AgentsPECORA FULCO, Patricia; MCNICHOLL, Lan R.Pharmacotherapy. 2009, Vol 29, Num 3, pp 281-294, issn 0277-0008, 14 p.Article

Powder for reconstitution of the anti-HIV-1 drug TMC278 -Formulation development, stability and animal studiesVAN GYSEGHEM, Elke; PENDELA, Murali; ADAMS, Erwin et al.European journal of pharmaceutics and biopharmaceutics. 2008, Vol 70, Num 3, pp 853-860, issn 0939-6411, 8 p.Article

Rilpivirine vs. efavirenz in HIV-1 patients with baseline viral load 100 000 copies/ml or less: week 48 phase III analysisMOLINA, Jean-Michel; CLUMECK, Nathan; PEDANT, Karla et al.AIDS (London). 2013, Vol 27, Num 6, pp 889-897, issn 0269-9370, 9 p.Article

Short-term antiviral activity of TMC278 : a novel NNRTI - in treatment-naive HIV-1-infected subjectsGOEBEL, Frank; YAKOVLEV, Alexy; POZNIAK, Anton L et al.AIDS (London). 2006, Vol 20, Num 13, pp 1721-1726, issn 0269-9370, 6 p.Article

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trialsNELSON, Mark; AMAYA, Gerardo; VANVEGGEL, Simon et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 8, pp 2020-2028, issn 0305-7453, 9 p.Article

Recent Advances in DAPYs and Related Analogues as HIV-1 NNRTIsXUWANG CHEN; PENG ZHAN; DONGYUE LI et al.Current medicinal chemistry. 2011, Vol 18, Num 3, pp 359-376, issn 0929-8673, 18 p.Article

Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trialPOZNIAK, Anton L; MORALES-RAMIREZ, Javier; BOVEN, Katia et al.AIDS (London). 2010, Vol 24, Num 1, pp 55-65, issn 0269-9370, 11 p.Article

Development of a liquid chromatographic assay for an anti-HIV tablet containing lamivudine, zidovudine and TMC278.HCLPENDELA, M; VAN GYSEGHEM, E; VAN DEN MOOTER, G et al.Journal of pharmaceutical and biomedical analysis. 2009, Vol 49, Num 2, pp 508-512, issn 0731-7085, 5 p.Article

  • Page / 1